These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11376267)

  • 61. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients.
    Brenner W; Conrad EU; Eary JF
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):189-95. PubMed ID: 15129700
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Significance of incidental intra-articular and peri-articular FDG avid foci on PET/CT.
    Cohen-Levy WB; Pretell-Mazzini J; Singer AD; Subhawong T; Greif DN; Jose J
    Acta Radiol; 2019 Jan; 60(1):78-84. PubMed ID: 29665710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Evaluation of various hepatic lesions with positron emission tomography].
    Son HB; Han CJ; Kim BI; Kim J; Jeong SH; Kim YC; Lee JO; Choi CY; Im SM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):472-80. PubMed ID: 12506252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Positron emission tomography imaging of musculoskeletal tumors in the shoulder girdle.
    Suzuki H; Watanabe H; Shinozaki T; Yanagawa T; Suzuki R; Takagishi K
    J Shoulder Elbow Surg; 2004; 13(6):635-47. PubMed ID: 15570232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.
    Okamura T; Kawabe J; Koyama K; Ochi H; Yamada R; Sakamoto H; Matsuda M; Ohashi Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():209-13. PubMed ID: 9879423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
    Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
    J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?
    Zhuang HM; Cortés-Blanco A; Pourdehnad M; Adam LE; Yamamoto AJ; Martínez-Lázaro R; Lee JH; Loman JC; Rossman MD; Alavi A
    Nucl Med Commun; 2001 Oct; 22(10):1123-8. PubMed ID: 11567186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter.
    Yeung HW; Sanches A; Squire OD; Macapinlac HA; Larson SM; Erdi YE
    Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):61-6. PubMed ID: 11807608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning.
    Beaulieu S; Rubin B; Djang D; Conrad E; Turcotte E; Eary JF
    AJR Am J Roentgenol; 2004 Apr; 182(4):971-4. PubMed ID: 15039173
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of FDG uptake with hybrid PET using standardised uptake values.
    Zimny M; Kaiser HJ; Wildberger J; Nowak B; Cremerius U; Sabri O; Buell U
    Eur J Nucl Med; 2001 May; 28(5):586-92. PubMed ID: 11383863
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 18F-FDG kinetics and gene expression in giant cell tumors.
    Strauss LG; Dimitrakopoulou-Strauss A; Koczan D; Bernd L; Haberkorn U; Ewerbeck V; Thiesen HJ
    J Nucl Med; 2004 Sep; 45(9):1528-35. PubMed ID: 15347720
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mediastinal hibernoma simulates a malignant lesion on dual time point FDG imaging.
    Burdick MJ; Jolles PR; Grimes MM; Henry DA
    Lung Cancer; 2008 Mar; 59(3):391-4. PubMed ID: 17905469
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.
    Kwee TC; de Klerk JMH; Nix M; Heggelman BGF; Dubois SV; Adams HJA
    Semin Nucl Med; 2017 Jul; 47(4):322-351. PubMed ID: 28583274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An analysis of the physiological FDG uptake pattern in the stomach.
    Koga H; Sasaki M; Kuwabara Y; Hiraka K; Nakagawa M; Abe K; Kaneko K; Hayashi K; Honda H
    Ann Nucl Med; 2003 Dec; 17(8):733-8. PubMed ID: 14971621
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
    Zhao S; Kuge Y; Tsukamoto E; Mochizuki T; Kato T; Hikosaka K; Hosokawa M; Kohanawa M; Tamaki N
    Eur J Nucl Med; 2001 Jun; 28(6):730-5. PubMed ID: 11440033
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitative assessment of tumor metabolism using FDG-PET imaging.
    Weber WA; Schwaiger M; Avril N
    Nucl Med Biol; 2000 Oct; 27(7):683-7. PubMed ID: 11091112
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer.
    Kato T; Tsukamoto E; Kuge Y; Takei T; Shiga T; Shinohara N; Katoh C; Nakada K; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1492-5. PubMed ID: 12397469
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anatomy of SUV. Standardized uptake value.
    Huang SC
    Nucl Med Biol; 2000 Oct; 27(7):643-6. PubMed ID: 11091106
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 18FDG-PET applications for cartilage neoplasms.
    Feldman F; Van Heertum R; Saxena C; Parisien M
    Skeletal Radiol; 2005 Jul; 34(7):367-74. PubMed ID: 15937711
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of uptake of 2-deoxy-2-[18F] fluoro-D-glucose by fungal-associated inflammation: the standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease.
    Bassett CL; Daniel GB; Legendre AM; Bochsler PN; Smith GT
    Mol Imaging Biol; 2002 May; 4(3):201-7. PubMed ID: 14537124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.